Tg Therapeutics (TGTX) Free Cash Flow: 2016-2025
Historic Free Cash Flow for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to -$23.2 million.
- Tg Therapeutics' Free Cash Flow fell 89.98% to -$23.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$70.2 million, marking a year-over-year decrease of 149.88%. This contributed to the annual value of -$40.6 million for FY2024, which is 29.12% down from last year.
- Per Tg Therapeutics' latest filing, its Free Cash Flow stood at -$23.2 million for Q3 2025, which was down 414.21% from $7.4 million recorded in Q2 2025.
- Tg Therapeutics' 5-year Free Cash Flow high stood at $83.7 million for Q3 2023, and its period low was -$87.0 million during Q4 2021.
- For the 3-year period, Tg Therapeutics' Free Cash Flow averaged around -$10.6 million, with its median value being -$13.2 million (2023).
- In the last 5 years, Tg Therapeutics' Free Cash Flow soared by 342.63% in 2023 and then crashed by 250.19% in 2025.
- Quarterly analysis of 5 years shows Tg Therapeutics' Free Cash Flow stood at -$87.0 million in 2021, then spiked by 72.56% to -$23.9 million in 2022, then soared by 44.67% to -$13.2 million in 2023, then crashed by 94.26% to -$25.7 million in 2024, then tumbled by 89.98% to -$23.2 million in 2025.
- Its last three reported values are -$23.2 million in Q3 2025, $7.4 million for Q2 2025, and -$28.7 million during Q1 2025.